About this trial
This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism.
The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE.
The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.
Eligibility criteria
Qualifiers
Age >= 18 years of age
ED diagnosis of acute pulmonary embolism with identification on CT imaging
Disqualifiers
Age <18 years of age
Inability to provide informed consent
Incarceration
Current PE previously diagnosed prior to index ED visit
Trial design
Treatments tested in this trial
- Point-of-care echocardiography
Treatment groups
Sponsors and collaborators
WellSpan Health
Lead sponsor
Stony Brook University
Collaborator
University of California, Irvine
Collaborator